Alice K. Jacobs

Q: What Schools Are Affiliated With Alice K. Jacobs

Alice K. Jacobs is affiliated with the following schools: Massachusetts General Hospital, Duke University, University of Antwerp, Boston University, University at Albany, SUNY, Albany Medical College, University of Oklahoma Health Sciences Center, Johns Hopkins University

Alice K. Jacobs's AcademicInfluence.com Rankings

Alice K. Jacobs

Computer Science

#3045

World Rank

#3193

Historical Rank

Database

#603

World Rank

#633

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Alice K. Jacobs Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Alice K. Jacobs is a professor at the Boston University Chobanian & Avedisian School of Medicine who specializes in interventional cardiology, coronary revascularization, and sex-based differences in cardiovascular disease.

(See a Problem?)

Alice K. Jacobs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients (2002) (3666)
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. (2002) (3500)
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography (2006) (3207)
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association (2002) (2821)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. (2002) (2786)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC (2006) (2631)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006) (2558)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (2552)
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. (2002) (2376)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (2315)
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (2258)
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients (2002) (2245)
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. (1999) (2210)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) (2009) (2012)
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie (2007) (1962)
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (2001) (1865)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (1807)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (1612)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (1569)
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). (2003) (1549)
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (1523)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (1467)
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (1407)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006) (1406)
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (1400)
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) (1400)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (1373)
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) (1319)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (1269)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (1224)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (1197)
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary (2010) (1162)
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation (2007) (1064)
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent (2006) (1040)
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (1008)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang (2006) (1006)
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (927)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article (2002) (893)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (888)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (880)
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008) (872)
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemaker (2008) (866)
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association (2017) (860)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (847)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co (2003) (786)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text (2006) (778)
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) (769)
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro (2001) (767)
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing co (2003) (731)
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary (2001) (728)
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (723)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (709)
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention (2013) (682)
One-year survival following early revascularization for cardiogenic shock. (2001) (642)
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (628)
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca (2003) (618)
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (590)
An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload (1972) (563)
ACCF/AHA Expert Conseusus Document (2009) (530)
Ferritin in the Serum of Normal Subjects and Patients with Iron Deficiency and Iron Overload (1972) (490)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati (2002) (479)
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. (2003) (428)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (426)
Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy (2004) (414)
[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. (2006) (412)
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (391)
Nonvalvular Cardiovascular Device–Related Infections (2003) (380)
Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease (2010) (378)
[ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]. (2006) (378)
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. (1995) (374)
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angi (2008) (369)
Low molecular weight intracellular iron transport compounds. (1977) (353)
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas (2001) (352)
Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy (2006) (350)
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. (2014) (348)
Ferritin in serum. Clinical and biochemical implications. (1975) (337)
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries (2000) (335)
Iron in biochemistry and medicine. (1974) (326)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (321)
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (317)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (315)
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? (2000) (303)
Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) (1998) (301)
Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. (2003) (260)
Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursi (2008) (258)
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2012) (256)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel (2006) (244)
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. (2015) (240)
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. (2005) (232)
Do fish oils prevent restenosis after coronary angioplasty? (1994) (232)
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. (2014) (229)
Defect of cell-mediated immunity in patients with iron-deficiency anaemia. (1972) (228)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) (2006) (226)
FMS mutations in myelodysplastic, leukemic, and normal subjects. (1990) (223)
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. (2010) (221)
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. (2014) (221)
Comparison of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting After Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results From the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial (2005) (210)
Recommendation to Develop Strategies to Increase the Number of ST-Segment–Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention (2006) (210)
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2012) (208)
Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. (2002) (205)
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat (2002) (204)
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002) (202)
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. (1986) (196)
Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry (2007) (195)
The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) (193)
Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. (2011) (193)
Aspirin resistance and atherothrombotic disease. (2005) (191)
Molecular imaging of gene therapy for cancer (2004) (186)
Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects (1979) (184)
Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting. (1999) (176)
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. (1997) (174)
CARCINOMA OF THE ŒSOPHAGUS AFTER GASTRIC SURGERY (1970) (172)
Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. (1992) (170)
RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. (1988) (167)
Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) (2002) (167)
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive summary (2011) (162)
Genes for hereditary sensory and autonomic neuropathies: a genotype–phenotype correlation (2009) (162)
Use of Emergency Medical Service Transport Among Patients With ST-Segment–Elevation Myocardial Infarction: Findings From the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry–Get With the Guidelines (2011) (161)
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. (2000) (158)
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. (2001) (158)
Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease: A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study (2002) (153)
ACC/AHA Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery (2002) (152)
Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. (2010) (152)
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (2004) (151)
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary (2012) (149)
Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia (1989) (149)
Ferritinaemia in Leukaemia and Hodgkin's Disease (1973) (143)
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline) (2012) (138)
ACCF/AHA Clinical Practice Guideline Methodology Summit Report: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (136)
ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology. (1998) (126)
The purification and properties of ferritin from human serum. (1976) (126)
The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin (1991) (125)
Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. (1991) (125)
Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Report From the American Heart Association’s Mission: Lifeline (2012) (124)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society (2012) (123)
Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. (1999) (120)
Binding of human serum ferritin to concanavalin A. (1979) (117)
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction [TIMI] II trial) (1993) (117)
Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. (2003) (117)
Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. (2007) (116)
Nonvalvular cardiovascular device-related infections. (2004) (116)
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography (2010) (115)
Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry. (2001) (115)
Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. (1995) (114)
The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification (1985) (114)
Properties of human tissue isoferritins. (1978) (113)
Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. (1992) (113)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. (2002) (105)
Occupational and environmental exposures and myelodysplasia: a case-control study. (1995) (105)
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (103)
Results of coronary angioplasty of chronic total occlusions (the National Heart, Lung, and Blood Institute 1985-1986 Percutaneous Transluminal Angioplasty Registry). (1992) (103)
Serum ferritin concentration in early breast cancer. (1976) (102)
Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. (1991) (101)
Congestive heart failure in patients with coronary artery disease: the gender paradox. (1997) (100)
Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). (2002) (99)
Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration. (1975) (99)
Time to treatment in patients with STEMI. (2013) (97)
Appropriateness of coronary revascularization for patients without acute coronary syndromes. (2012) (94)
Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome (1990) (94)
Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot–Marie–Tooth neuropathy (2009) (93)
Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). (2001) (93)
ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health Records: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (2011) (93)
Circulating erythropoietin in patients with myelodysplastic syndromes (1989) (92)
Clonal lymphocytes are detectable in only some cases of MDS (1992) (91)
Recent trends in the percutaneous treatment of chronic total coronary occlusions. (2006) (91)
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. (1996) (90)
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. (2013) (90)
Ferrokinetics and Erythropoiesis in Man: The Measurement of Effective Erythropoiesis, Ineffective Erythropoiesis and Red Cell Lifespan using 59Fe (1975) (89)
Management of Patients Undergoing Percutaneous Coronary Revascularization (2003) (88)
The degree of revascularization and outcome after multivessel coronary angioplasty. (1992) (88)
A randomized trial of 13‐cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome (1987) (87)
Regionalized care for patients with ST-elevation myocardial infarction: it's closer than you think. (2006) (87)
Effective Iron Chelation following Oral Administration of an Isoniazid‐Pyridoxal Hydrazone (1979) (87)
Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? (2000) (87)
Coronary revascularization in women in 2003: sex revisited. (2003) (86)
Binding of Serum Ferritin to Concanavalin A: Patients with Hornozygous β Thalassaemia and Transfusional Iron Overload (1980) (86)
Internal regulation of iron absorption (1975) (84)
ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis (2008) (83)
Regional systems of care for patients with ST-elevation myocardial infarction: being at the right place at the right time. (2007) (81)
Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease (2013) (80)
ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 199 (2007) (80)
Comparative Outcomes for Patients Who Do and Do Not Undergo Percutaneous Coronary Intervention for Stable Coronary Artery Disease in New York (2012) (80)
An intracellular transit iron pool. (2008) (80)
Iron uptake by Chang cells from transferrin, nitriloacetate and citrate complexes: the effects of iron-loading and chelation with desferrioxamine. (1978) (79)
Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). (2007) (78)
Quantitative kinetics of [124I]FIAU in cat and man. (2001) (78)
Coronary intervention in 2009: are women no different than men? (2009) (78)
Guidelines for the Management of Patients With Supraventricular Arrhythmias * — Executive Summary (2003) (78)
Serum ferritin in patients with cancer: determination with antibodies to HeLa cell and spleen ferritin. (1980) (75)
Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention (2003) (74)
Factors associated with poorer prognosis for patients undergoing primary percutaneous coronary intervention during off-hours: biology or systems failure? (2008) (74)
Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures (2007) (73)
Ferritin in Normal Erythrocytes, Lymphocytes, Polymorphs, and Monocytes (1974) (72)
Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer. (2006) (71)
Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry. (2011) (71)
The effect of chelating agents on cellular iron metabolism. (1976) (70)
Ferritin synthesis in normal and leukaemic leukocytes (1974) (69)
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. (1999) (69)
Women, ischemic heart disease, revascularization, and the gender gap: what are we missing? (2006) (69)
Outcome after major dissection during coronary angioplasty using the perfusion balloon catheter. (1991) (68)
Myelodysplasia, chemical exposure, and other environmental factors. (1989) (68)
EFFECT OF 13-cis-RETINOIC ACID ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (1987) (68)
Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). (2013) (67)
Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35. (2003) (67)
Mutations in the small GTPase late endosomal protein RAB 7 cause Charcot-Marie-Tooth type 2 B neuropathy (2007) (67)
Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for st-segment elevation myocardial infarction. (2010) (67)
Ferritin in Blood Cells from Normal Subjects and Patients with Leukaemia (1974) (67)
Primary angioplasty for acute myocardial infarction--is it worth the wait? (2003) (65)
The cardiovascular state of the union: confronting healthcare disparities. (2005) (65)
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). (1999) (64)
The Effects of Iron Deficiency on the Respiratory Function and Cytochrome Content of Rat Heart Mitochondria (1976) (64)
Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience. (2004) (63)
Serum Ferritin in Acute Leukaemia at Presentation and during Remission (1975) (62)
Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. (2014) (60)
30-day readmission for patients undergoing percutaneous coronary interventions in New York state. (2011) (60)
Task force 3: training in diagnostic and interventional cardiac catheterization endorsed by the Society for Cardiovascular Angiography and Interventions. (2008) (59)
Improving Care of STEMI in the United States 2008 to 2012 (2018) (58)
Transferrin Iron, Chelatable Iron and Ferritin in Idiopathic Haemochromatosis (1974) (57)
Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). (2013) (56)
Nonemergency PCI at hospitals with or without on-site cardiac surgery. (2013) (56)
The characteristics of ferritin from human tissues, serum and blood cells. (1975) (55)
Expression of the multiple drug resistance gene (mdr‐1) and epitope masking in chronic lymphatic leukaemia (1990) (55)
Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention (2012) (55)
Trial of strategy for reducing the use of laboratory tests. (1986) (54)
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group. (1994) (54)
TISSUE CHANGES IN IRON DEFICIENCY (1969) (54)
Serum ferritin concentration in untreated Hodgkin's disease. (1976) (53)
Green fluorescent protein as a reporter for retrovirus and helper virus‐free HSV‐1 amplicon vector‐mediated gene transfer into neural cells in culture and in vivo (1997) (53)
Is the mdr 1 gene relevant in chronic lymphocytic leukemia? (1990) (52)
Ferritin Synthesis in Lymphocytes, Polymorphs and Monocytes (1975) (52)
The Measurement of Reticuloendothelial Iron Release using Iron—Dextran (1971) (52)
Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions: Characteristics, Success, and Outcomes (2016) (51)
In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. (1989) (51)
Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. (2009) (50)
Expanding phenotype of XNP mutations: mild to moderate mental retardation. (2002) (50)
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993–1994 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry) (1997) (49)
Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I) (1997) (49)
Iron metabolism, sickle cell disease, and response to cyanate. (1975) (48)
Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplasty. (1992) (48)
Human preleukaemia: do we have a model? (1987) (47)
Impact of Incomplete Revascularization on Long-Term Mortality After Coronary Stenting (2011) (47)
Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies. (2010) (47)
Evaluating and managing cardiovascular disease in women: understanding a woman's heart. (2005) (46)
Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. (2003) (46)
America's children: a critical time for prevention. (2005) (46)
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. (1999) (46)
The biochemistry of ferritin and its clinical implications. (1975) (45)
Non-haematological effects of iron deficiency. (1977) (45)
DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS) (1986) (45)
The application of X‐chromosome gene probes to the diagnosis of myeloproliferative disease (1989) (45)
Ferritin Concentration in Normal and Abnormal Erythrocytes Measured by Immunoradiometric Assay with Antibodies to Heart and Spleen Ferritin and Mössbauer Spectroscopy (1981) (45)
SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I (2004) (44)
Role of gastric secretion in iron absorption. (1969) (44)
Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry® (2016) (44)
Appropriateness of Diagnostic Catheterization for Suspected Coronary Artery Disease in New York State (2014) (43)
Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial. (2009) (43)
Erythropoiesis and the Effect of Transfusion in Homozygous β-Thalassemia (1978) (43)
Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes. (2006) (43)
Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. (1986) (43)
Gastric Acidity and Iron Absorption (1966) (43)
Comparability of quality-of-care indicators for emergency coronary angioplasty in patients with acute myocardial infarction regardless of on-site cardiac surgery (report from the National Registry of Myocardial Infarction). (2004) (42)
Pathogenesis and clinical variations in the myelodysplastic syndromes. (1986) (42)
The Oral Lesions of Iron Deficiency Anaemia: Pyridoxine and Riboflavin Status (1968) (42)
Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age (2016) (42)
2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement (2012) (42)
RAS mutations in patients following cytotoxic therapy for lymphoma. (1990) (42)
The clearance of 131I-human plasma ferritin in man (1982) (42)
Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction (2013) (41)
Cerebral air embolism as a cause of stroke during cardiac catherization (1998) (41)
Outcomes for Patients With ST-Elevation Myocardial Infarction in Hospitals With and Without Onsite Coronary Artery Bypass Graft Surgery: The New York State Experience (2009) (41)
Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). (2003) (41)
The Iron Content of Intestinal Epithelial Cells and Its Subcellular Distribution: Studies on Normal, Iron‐Overloaded and Iron‐Deficient Rats (1972) (40)
The Metabolism of Intravenously Administered Iron‐Dextran (1973) (39)
Leukaemia Research Fund annual guest lecture 1990. Genetics lesions in preleukaemia. (1991) (39)
Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II). (1992) (39)
American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus documents. (1999) (39)
Diagnostic Methods for Iron Status (1986) (39)
The Measurement of Reticuloendothelial Iron Release using Iron–Dextran (1971) (39)
Ferritin Polymers and the Formation of Haemosiderin (1981) (38)
Iron Metabolism in Hodgkin's Disease (1972) (38)
Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response (2007) (38)
The Effect of Desferoxamine on Fibroblasts and Collagen Formation in Cell Cultures (1979) (38)
Aspirin resistance: current concepts. (2004) (38)
Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data. (1990) (38)
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) (2002) (38)
Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma. (2000) (38)
Intraluminal transport of iron from stomach to small-intestinal mucosa (1969) (38)
The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (37)
Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy. (2015) (37)
Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations (2012) (37)
Defining and measuring successful emergency care networks: a research agenda. (2010) (37)
Expert Consensus Document Accf/acr/aha/nasci/scmr 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance a Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Writing Committee Members Expert Consensus Document Table of Contents Hundley Et Al (2010) (36)
Serum ferritin and iron stores. (1977) (36)
Erythrocyte ferritin in normal subjects and patients with abnormal iron metabolism (1983) (36)
Ferrokinetics and Erythropoiesis in Man: Red‐Cell Production and Destruction in Normal and Anaemic Subjects (1977) (36)
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 3: training in cardiac catheterization and interventional cardiology. (1995) (35)
The Origin of Androgen and Estrogen in a Virilized Postmenopausal Woman With Bilateral Benign Cystic Teratomas (1977) (35)
THE CLINICAL USE OF SERUM FERRITIN ESTIMATION (1975) (35)
Rebuilding an enduring trust in medicine: a global mandate: presidential address American Heart Association Scientific Sessions 2004. (2005) (35)
Iron overload in Chang cell cultures: biochemical and morphological studies. (1978) (35)
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer (1998) (35)
Iron Uptake and Ferritin Synthesis by Peripheral Blood Leucocytes in Patients with Primary Idiopathic Haemochromatosis (1981) (35)
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 199 (2007) (35)
Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria. (2017) (35)
Primary myelodysplastic syndrome and cancer. (1987) (34)
Disparities by race, ethnicity, and sex in treating acute coronary syndromes. (2012) (34)
Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty. (1989) (34)
The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry. (2006) (34)
Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes (1990) (34)
The formation of iron complexes with bile and bile constituents (1970) (34)
Erythrocyte transaminase activity. Effect of age, sex, and vitamin B6 supplementation. (1968) (33)
Iron Uptake and Ferritin Synthesis by Peripheral Blood Leucocytes from Normal Subjects and Patients with Iron Deficiency and the Anaemia of Chronic Disease (1976) (33)
Interaction of ferritin with serum: implications for ferritin turnover. (1984) (33)
THE BUCCAL MUCOSA IN ANAEMIA (1960) (33)
Ferritin: an interim review. (1985) (33)
Gastric acid secretion in chronic iron-deficiency anaemia. (1966) (33)
The development of new iron-chelating drugs. II. (1978) (32)
The effects of iron deficiency on rat liver enzymes. (1975) (32)
Absorption of 59 Fe in the rat: iron binding substances in the soluble fraction of intestinal mucosa. (1971) (32)
Isoferritins in normal leucocytes (1983) (32)
Iron and isoferritins in iron overload. (1982) (32)
Enrichment of erythroblasts from human bone marrow using complement‐mediated lysis: measurement of ferritin (1983) (32)
Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). (2011) (32)
Risk Stratification for Long-Term Mortality After Percutaneous Coronary Intervention (2014) (32)
Availability of Food Iron (1969) (31)
Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload (1982) (31)
Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor. (1988) (31)
Erythroblast iron metabolism in sideroblastic marrows (1982) (31)
Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty. (1989) (31)
The measurement of 59Fe clearance from the plasma. (2009) (30)
Circulating micromegakaryocytes in myelodysplasia. (1987) (30)
The New York State risk score for predicting in-hospital/30-day mortality following percutaneous coronary intervention. (2013) (30)
Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes. (1985) (30)
Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV (2006) (30)
Annotation IRON CHELATION THERAPY FOR IRON LOADED PATIENTS (1979) (30)
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic (1992) (30)
c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines. (1989) (30)
Cerebral air embolism as a cause of stroke during cardiac catheterization. (1998) (29)
Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). (1999) (29)
The reactivity of isoferritins in a labelled antibody assay. (1976) (28)
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. (2016) (28)
Turnover of 131I‐human spleen ferritin in plasma (1983) (28)
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. (2011) (28)
Biology and pathogenesis of the myelodysplastic syndromes. (1992) (28)
The Use of Chang Cells Cultured in Vitro to Evaluate Potential Iron Chelating Drugs (1976) (27)
Incidence and prognosis of intra-abdominal hypertension and abdominal compartment syndrome in severely burned patients: Pilot study and review of the literature. (2016) (27)
Extended cytogenetic follow‐up of patients with myelodysplastic syndrome (MDS) (1992) (27)
Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes. (2010) (27)
Non-ferritin Iron Compound in Rat Small Intestinal Mucosa during Iron Absorption (1971) (27)
The Subcellular Distribution of Orally Administered 59Fe in Rat Small Intestinal Mucosa (1971) (27)
Extended cytogenetic follow-up and clinical progress in patients with myelodysplastic syndromes (MDS). (1994) (26)
Changing profiles of failed coronary angioplasty patients: impact on surgical results. (1992) (26)
The Subcellular Distribution of 59Fe in Small Intestinal Mucosa: Studies with Normal, Iron Deficient and Iron Overloaded Rats (1972) (26)
Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status. (1992) (26)
Electrophilic sulfenylation in a stereocontrolled synthesis of protected (2R,3R)-3-mercaptoaspartic acid from L-aspartic acid (1996) (25)
The clearance of 131I-human plasma ferritin in man. (1982) (25)
Ferrokinetics and Erythropoiesis in Man: An Evaluation of Ferrokinetic Measurements (1977) (25)
Paradoxical coronary embolism: a rare cause of acute myocardial infarction. (2003) (25)
Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids. (1978) (25)
Predictive testing for cognitive functioning in female carriers of the fragile X syndrome using hair root analysis (2003) (25)
Development of systems of care for ST-elevation myocardial infarction patients: policy recommendations. (2007) (25)
Long-term outcome of patients after percutaneous transluminal coronary angioplasty. (1990) (25)
Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid. (1987) (25)
Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group. (1993) (24)
The iron-binding properties of gastric juice. (1969) (24)
Colony‐cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high‐risk myelodysplasia (1991) (24)
Morphological abnormalities in lymphocyte mitochondria associated with iron-deficiency anaemia (1974) (24)
THE IRON CONTENT OF FINGER NAILS. (1960) (24)
Effect of gastric juice on iron absorption in patients with gastric atrophy. (1969) (24)
Iron deficiency and iron overload. (1985) (24)
Expression of the colony-stimulating factor 1 receptor in B lymphocytes. (1993) (24)
Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With Incomplete Revascularization (2017) (24)
Non-dysplastic myelodysplasia? (1994) (24)
Secondary surgical‐site infection after coronary artery bypass grafting: A multi‐institutional prospective cohort study (2017) (23)
The effect of age on iron absorption. (1969) (23)
Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. (1997) (23)
Pyridoxine and Riboflavin Status in the Paterson — Kelly Syndrome (1968) (23)
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. (1997) (23)
The utilization of cardiac imaging. (2006) (23)
Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia. (1997) (22)
Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors (2005) (22)
Accumulation of storage iron in patients treated for iron-deficiency anaemia. (1975) (22)
The effect of isoferritins on granulopoiesis (1986) (22)
The effect of retinoids on CFU‐GM from normal subjects and patients with myelodysplastic syndrome (1985) (22)
Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry. (2007) (21)
HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation (2007) (21)
Safety and clinical use of exercise testing one to three days after percutaneous transluminal coronary angioplasty. (1992) (21)
The effect of iron stores on iron absorption in the rat: the possible role of circulating ferritin. (1975) (20)
Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents. (2013) (20)
Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma. (1989) (20)
Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein. (1991) (20)
The effect of chelating agents on iron mobilization in Chang cell cultures (1976) (20)
Minimal diagnostic criteria for the myelodysplastic syndrome. (1992) (20)
Coronary stents--have they fulfilled their promise? (1999) (20)
Iron chelation in cell cultures by two conjugates of 2,3-dihydroxybenzoic acid (2,3 -DHB). (1977) (20)
Coronary sinus occlusion pressure and its relation to intracardiac pressure. (1985) (19)
Pacemaker Guidelines) Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 American College of Cardiology/American Heart Association Task Force on Pacemakers and Antiarrhythmia Devices: Summary Article : A Report of the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac (2006) (19)
In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and Treatment (2018) (19)
Aha Policy Statement Variable Impact of State Legislative Advocacy on Registry Participation and Regional Systems of Care Implementation a Policy Statement from the American Heart Association on Behalf of the American Heart Association Advocacy Coordinating Committee (19)
Percutaneous Coronary Intervention) (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Cardiology/American Heart Association Task Force on Practice Guidelines Intervention—Summary Article: A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary (2006) (19)
Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing. (1991) (19)
Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation (2005) (19)
Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes. (1986) (19)
Coronary Chronic Total Occlusion (CTO): A Review. (2018) (18)
Haematological disorders and occupational hazards: a British Society for Haematology/Health and Safety Executive study (1993) (18)
FMS mutations in patients following cytotoxic therapy for lymphoma. (1995) (18)
Primary acquired sideroblastic erythropoiesis in non-anaemic and minimally anaemic subjects. (1989) (18)
Erythroid colony growth from peripheral blood and bone marrow in polycythaemia. (1990) (18)
The use of Chang cells cultured in vitro for the investigation of cellular iron metabolism. (1975) (18)
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia (1992) (18)
Percutaneous Coronary Intervention in the Current Era Compared With 1985 – 1986 (2000) (17)
Gene mutations in myelodysplasia. (1992) (17)
Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA’s Mission: Lifeline (2020) (17)
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association. (2021) (17)
Erythropoiesis and iron metabolism in Hodgkin's disease. (1979) (17)
Task force 3: Training in diagnostic and interventional cardiac catheterization: Endorsed by the Society for Cardiovascular Angiography and Interventions (2008) (17)
Changes in the characteristics and distribution of ferritin in iron-loaded cell cultures. (1981) (17)
PRIMARY ACQUIRED SIDEROBLASTIC ANAEMIA (1986) (17)
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry. (2011) (17)
Underutilization of percutaneous coronary intervention for ST-elevation myocardial infarction in medicaid patients relative to private insurance patients. (2013) (16)
Ascorbic acid status in iron-deficiency anaemia (1971) (16)
Iron Transport by Rat Small Intestine in Vitro: Effect of Body Iron Status (1972) (16)
Combined HSV‐1 recombinant and amplicon piggyback vectors: replication‐competent and defective forms, and therapeutic efficacy for experimental gliomas (1999) (16)
Nuclear c‐myc protein, maturation, and cell‐cycle status of human haemopoietic cells (1987) (16)
Carbohydrates and sulphur-containing compounds in the anaemic buccal epithelium (1961) (16)
Serum ferritin and malignant tumours (1984) (16)
A Random Sample from Wales (1969) (16)
Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial). (2011) (16)
RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia. (1995) (16)
Detection of intracoronary fibrin degradation after coronary balloon angioplasty. (1991) (16)
Antecedent angina: a predictor of residual stenosis after thrombolytic therapy. (1989) (16)
Emergency medical services management of ST-segment elevation myocardial infarction in the United States--a report from the American Heart Association Mission: Lifeline Program. (2014) (16)
Transferrin-bipyridine iron transfer mediated by haemoproteins. (1980) (15)
Isochromosome (6p) in Waldenstrom's macroglobulinemia. (1992) (15)
Sex Differences in Ischemic Heart Disease-the Paradox Persists. (2020) (15)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention (2008) (15)
Primary PTCA versus thrombolytic therapy: an evidence-based summary. (1999) (15)
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia (1992) (15)
IRON CHELATION WITH ORAL DESFERRIOXAMINE (1980) (15)
The ferritin content of normoblasts and megaloblasts from human bone marrow. (1986) (15)
2012 American college of cardiology foundation/society for cardiovascular angiography and interventions expert consensus document on cardiac catheterization laboratory standards update: American college of cardiology foundation task force on expert consensus documents society of thoracic surgeons so (2012) (15)
Sex differences in iron absorption (1976) (15)
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. (1997) (15)
Application of Echocardiography) (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Cardiology/American Heart Association Task Force on Practice Guidelines Echocardiography: Summary Article: A Report of the American College of ACC/AHA/ASE 2003 Guideline Update for the Clinical App (2006) (14)
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York (2020) (14)
Comparison of 3-Year Outcomes for Coronary Artery Bypass Graft Surgery and Drug-Eluting Stents: Does Sex Matter? (2015) (14)
Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New York. (2014) (14)
A rapid method for the detection of ferritin in serum. (1971) (14)
Globin chain synthesis ratios in sideroblastic anaemia (1983) (14)
Sex-Based Differences in Discharge Disposition and Outcomes for ST-Segment Elevation Myocardial Infarction Patients Within a Regional Network. (2018) (14)
Control of Iron Absorption in Hemochromatosis (1988) (14)
Isoferritins in acute leukaemia. (1977) (14)
Erythropoiesis and the effect of transfusion in homozygous beta-thalassemia. (1978) (13)
Testosterone, erythropoietin and anaemia in patients with disseminated bronchial cancer (1984) (13)
Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty. (1991) (13)
Effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on single CD34-positive hemopoietic progenitors from human bone marrow. (1989) (13)
Anaemia and Post-Cricoid Carcinoma (1961) (13)
A Random Sample from Wales (1969) (13)
Iron Absorption: Present State of the Art (1975) (13)
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group. (1989) (13)
Importance of the postdischarge interval in assessing major adverse clinical event rates following percutaneous coronary intervention. (2005) (13)
DO ACIDIC ISOFERRITINS REGULATE HAEMOPOIESIS? (1983) (12)
A Stereocontrolled Synthesis of Protected (2R,3R)-3-Mercaptoaspartic Acid via a β-Aspartyl Enolate Sulfenylation (1996) (12)
Oncogenes in the myelodysplastic syndrome. (1989) (12)
Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus. (2006) (12)
The chelation of iron during intestinal absorption. (1969) (12)
Coronary calcium screening and the American Heart Association news embargo. (2004) (12)
IRON STORES AND IRON ABSORPTION (1973) (12)
Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications. (2004) (12)
Anaemia in patients with myelomatosis. (1982) (12)
Testosterone, erythropoietin and anaemia in patients with disseminated bronchial cancer. (1984) (12)
(Committee on the Management of Patients With Chronic Stable Angina) Cardiology/American Heart Association Task Force on Practice Guidelines Stable Angina—Summary Article: A Report of the American College of ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic (2008) (12)
Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and Hospital. (2016) (12)
Primary percutaneous coronary intervention without cardiac surgery on-site: coming to a hospital near you? (2008) (12)
Prehospital Activation of Hospital Resources (PreAct) ST‐Segment–Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline Program (2020) (12)
Trends in major entry site complications from percutaneous coronary intervention (from the Dynamic Registry). (2014) (11)
The Ha-ras polymorphism in myelodysplasia and acute myeloid leukaemia. (1988) (11)
Gulf of Mexico Ocean Monitoring System (1998) (11)
BENZENE AND LEUKAEMIA (1989) (11)
Outcome of percutaneous coronary intervention in unstable angina pectoris versus stable angina pectoris in two different time periods. (2006) (11)
Taking the Reins on Systems of Care for ST-Segment–Elevation Myocardial Infarction Patients: A Report From the American Heart Association Mission Lifeline Program (2018) (11)
Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women (2005) (11)
Coronary angioplasty and surgical revascularization: emerging concepts. (1995) (11)
Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. (2018) (11)
The effect of chelating agents on iron mobilization in Chang cell cultures. (1976) (11)
The response of intracellular and surface ferritin after T-cell stimulation in vitro. (1987) (11)
The expression of cell surface ferritin by peripheral blood lymphocytes and monocytes (1984) (11)
Clonal haemopoiesis following cytotoxic therapy for lymphoma. (1993) (11)
Serum ferritin during unmaintained remission in acute lymphoblastic leukaemia. (1978) (11)
Radioiron and erythropoiesis: methods, interpretation and clinical application. (1977) (11)
METABOLIC CONSEQUENCES OF IRON OVERLOAD (1976) (11)
The clearance of a single i.v. bolus of recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes and its effects on erythropoiesis. (1991) (11)
Iron Turnover in the Skin (1969) (10)
Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer. (1988) (10)
Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPA. (1995) (10)
Iron absorption and distribution in normal and scorbutic guinea pigs. (1972) (10)
Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma. (1992) (10)
Biochemical and immunological characteristics of ferritin from HL-60, U-937 and K-562 cell lines: implications for haemopoietic regulation. (1984) (10)
DNA index and karyotype analysis in myelodysplasia. (1989) (10)
Biochemical and Immunological Characterization of Ferritin from Leukaemic Cells (1980) (10)
Genetic abnormalities in the myelodysplastic syndrome. (1991) (10)
Effect of phytohaemagglutinin on the synthesis and secretion of ferritin in peripheral blood lymphocytes (1988) (10)
Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India (2017) (10)
Everolimus‐eluting stents and zotarolimus‐eluting stents for percutaneous coronary interventions (2013) (10)
Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction. (2011) (10)
F1000Prime recommendation of Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. (2011) (10)
FMRP expression studies in blood and hair roots in a fragile X family with methylation mosaics (2003) (10)
Peripheral blood chromosome aberrations in MDS. (1992) (10)
Aspyrone biosynthesis in Aspergillus melleus: identification of the intermediates formed on the polyketide synthase (PKS) in the first chain extension cycle leading to crotonate (1991) (10)
Evidence of acute demyelination around a developmental venous anomaly: magnetic resonance imaging findings. (1997) (10)
Drosophila as a platform to predict the pathogenicity of novel aminoacyl-tRNA synthetase mutations in CMT (2012) (9)
A screen for RAS mutations in individuals at risk of secondary leukaemia due to occupational exposure to petrochemicals. (1995) (9)
Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics (2017) (9)
Cell-cycle progression rates and sister chromatid exchange frequencies in the bone marrow of patients with myelodysplastic syndrome and acute myeloid leukemia. (1992) (9)
Utilization of Iron Dextran (1971) (9)
Interferon Alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Cancer (2000) (9)
Effect of Gastric Juice and pH on Inorganic Iron in Solution (1967) (9)
Myelodysplastic syndrome in a kindred with ins(16) (p11.2) (1988) (9)
Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome. (1988) (9)
Enrichment of haemopoietic progenitor cells from the marrow of patients with myelodysplasia (1988) (9)
Towards non-invasive imaging of HSV-1 vector-mediated gene expression by positron emission tomography. (2002) (8)
Cardiovascular disease in women: are there solutions? (2004) (8)
Iron kinetics in the skin of patients with iron overload. (1972) (8)
The Hemodynamic Consequences of Coronary Sinus Occlusion (1984) (8)
IRON DEFICIENCY AND THE ORAL MUCOUS MAMBRANE (1969) (8)
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative Group. (1992) (8)
Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins. (1990) (8)
Cellular proliferation and susceptibility to iron toxicity in iron loaded cell cultures. (2009) (8)
Erythrocyte transaminase activity in iron deficiency anaemia. (2009) (8)
Effects of branched-chain fatty acids on GABA-degradation and behavior: Further evidence for a role of GABA in quasi-morphine abstinence behavior (1980) (8)
Iron Metabolism in the Bone Marrow (1985) (7)
Erythrocyte ferritin concentration in patients with myelodysplastic syndromes. (1985) (7)
Dietary iron and haematological status in normal subjects. (1967) (7)
Iron uptake and ferritin synthesis in human erythroblasts. (1986) (7)
Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial (2015) (7)
HSV-1 Vectors for Gene Therapy of Experimental CNS Tumors. (2000) (7)
The effect of iron deficiency on the tissues. (1971) (7)
Coronary sinus occlusion: effect on ischemic left ventricular dysfunction and reactive hyperemia. (1991) (7)
Association Task Force on Practice Guidelines A Report of the American College of Cardiology Foundation/American Heart Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous With ST-Elevation Myocardial Infarction (2009) (7)
Iron Kinetics in the Skin (1971) (7)
Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women: Results From the DAPT Study (2018) (7)
Effect of 5637-conditioned medium on peripheral blood granulocyte-macrophage progenitors in normal subjects and patients with the myelodysplastic syndrome. (1989) (7)
Erythropoiesis, iron stores and tissue iron exchange in man. (1979) (7)
SKIN CLEARANCE OF IRON IN NORMAL AND IRON DEFICIENT SUBJECTS (1970) (6)
Assessment of the new appropriate use criteria for diagnostic catheterization in the detection of coronary artery disease following noninvasive stress testing. (2014) (6)
Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization (2022) (6)
The measurement of circulating ferritin. (1972) (6)
The myelodysplastic syndrome. (1990) (6)
Neuro-cognitive and behavioural aspects in non-specific mental retardation. A proposal for phenotyping new XLMR genes. (2002) (6)
The Effect of Pressure Controlled Intermittent Coronary Sinus Occlusion During Ischemia (1984) (6)
Variable Impact of State Legislative Advocacy on Registry Participation and Regional Systems of Care Implementation: A Policy Statement From the American Heart Association (2013) (6)
The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting. (2017) (6)
Sex differences in the treatment and outcomes of patients hospitalized with ST‐elevation myocardial infarction (2020) (6)
Appropriate revascularization in stable angina: lessons from the BARI 2D trial. (2014) (6)
Interleukin-3 plus low-dose cytosine arabinoside for advanced myelodysplasia: a pilot study. EORTC Leukemia Group. (1996) (6)
Clinical guidelines and performance measures; responsible guidance and accountability. (2010) (6)
Evaluation for Noncardiac Surgery) (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Cardiology/American Heart Association Task Force on Practice Guidelines Noncardiac Surgery—Executive Summary A Report of the American College of ACC/AHA Guideline Update for Perioperative Card (2008) (6)
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF) (1992) (5)
Renal insufficiency, bleeding and prescription of discharge medication in patients undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. (2016) (5)
The “stack perfusion catheter” improves outcome following dissection during coronary angioplasty (1990) (5)
Dynamic arm exercise during cardiac catheterization in the assessment of stenotic valvular disease (1990) (5)
Expert Consensus Document Accf/acr/aha/nasci/saip/scai/scct 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography a Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Writing Committee Members Expert Consensus Document Table of Cont (5)
Inhibition of erythroid colony growth in vitro by serum from patients with disseminated bronchial cancer. (1984) (5)
Ethics and professionalism: can there be consensus? An editorial comment on the report of the ACCF/AHA Consensus Conference on Professionalism and Ethics. (2004) (5)
SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization (2022) (5)
GENDER DISPARITIES IN ST-ELEVATION MYOCARDIAL INFARCTION CARE AND OUTCOMES IN EMERGING COUNTRIES: A GLOBAL LUMEN ORGANIZATION FOR WOMEN (GLOW) INITIATIVE AND CALL TO ACTION (2016) (5)
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. (2013) (5)
The efficacy of drug-eluting stents in women: a window of opportunity. (2009) (5)
MENSTRUAL BLOOD LOSS IN IRON DEFICIENCY ANAEMIA (1966) (5)
Coronary sinus assessment of left ventricular pressure in man (1983) (5)
Incomplete Revascularization in Patients Treated With Percutaneous Coronary Intervention: When Enough Is Enough. (2016) (5)
Erythropoietin and the myelodysplastic syndrome. (1991) (5)
2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings. (2018) (5)
Letter: Serum ferritin. (1976) (5)
Iron chelation therapy for iron loaded patients. (1979) (5)
Assessment of DNA content and cell cycle distribution of erythroid and myeloid cells from bone marrow. (1988) (5)
Case report of a coronary anomaly: crossing obtuse marginal arteries. (1991) (5)
Familial myelodysplasia. (1989) (5)
Acid Secretion by the Stomach in Pernicious Anaemia * (1958) (5)
A random sample from Wales. 3. Serum iron, iron binding capacity and transferrin saturation. (1969) (5)
Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention. (2005) (5)
Do the ethnic differences in presentation and treatment strategy influence outcomes of contemporary percutaneous coronary intervention? A report from the national heart, lung, and blood institute dynamic registry (2003) (4)
The Association of Socio-Economic Factors with Percutaneous Coronary Intervention Outcomes. (2021) (4)
Computers in Haematology (1975) (4)
ras Mutations in the Myelodysplastic Syndromes (1992) (4)
Effect of prolonged administration of an anticholinergic drug, propantheline bromide, on gastric histology and acid secretion (1968) (4)
Long-term clinical follow-up of patients successfully treated with a perfusion balloon catheter for coronary angioplasty-induced dissections or abrupt closure. (1994) (4)
A 19-year-old female with tamponade and systemic lupus erythematosus (SLE). (2015) (4)
The effect of isoferritins on granulopoiesis. (1986) (4)
The non-haematological effects iron deficiency. (1977) (4)
Red cell riboflavin in iron deficiency anaemia. (1967) (4)
Prospects of molecular imaging in neurology (2002) (4)
Tout le monde a sa place? MIRAB, education, and society in Wallis and Futuna (2017) (4)
The effect of pressure controlled intermittent coronary sinus occlusion during reperfusion (1986) (4)
c-myc protein kinetics during growth and differentiation of CD34 (MY10)-positive blast cells from normal human marrow. (1989) (4)
Strategies to improve early reperfusion in ST-elevation myocardial infarction. (2007) (4)
Are Women No Different Than Men? (2009) (4)
Investigation of the stereochemistry of the dehydration of the diketide, (3R)-3-hydroxybutyrate to crotonate, in the first chain extension cycle on the aspyrone polyketide synthase in intact cells of Aspergillus melleus (1995) (4)
Dual-Antiplatelet Therapy: Why Stop Now? (2016) (4)
Iron kinetics in muscle. (1971) (4)
Phagocytosis in normal and anaemic blood (1964) (4)
The Measurement of Iron Clearance from the Skin (1968) (4)
Iron balance and absorption. (1975) (3)
Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients: The Impact on the Assessment of Hospital Quality (2016) (3)
Control of iron absorption in hemochromatosis. Mucosal iron kinetics in vivo. (1988) (3)
Growth response to cytokines of circulating myeloid progenitors from myelodysplastic patients at diagnosis and more than 600 days after diagnosis (1991) (3)
Synaptopodin and 4 novel genes identified in primary sensory neurons (2005) (3)
IRON ABSORPTION IN IRON-LOADING ANÆMIAS (1977) (3)
Clinical guidelines and performance measures responsible guidance and accountability. (2010) (3)
Inadequacy of current criteria for predicting high risk coronary angioplasty (1990) (3)
Synchronized coronary venous retroperfusion. (1994) (3)
Leucocyte oxygen consumption in iron deficiency anaemia. (1965) (3)
Gastric Factors Influencing Iron Absorption in Anaemic Patients (2009) (3)
[Varicella-zoster-virus myelitis without herpes. An important differential diagnosis of the radicular syndrome]. (2008) (3)
Incidence and prognosis of intra‐abdominal hypertension and abdominal compartment syndrome in severely burned patients (2010) (3)
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. (2011) (3)
O2 for STEMI: Still Up in the Air (2015) (3)
Letter: alpha2H-globulin and ferritin. (1975) (3)
In-hospital ST-segment-elevation myocardial infarction: an inside-out approach. (2014) (3)
730-6 Histopathologic Findings in Ostial Coronary Lesions Treated with Directional Atherectomy (1995) (3)
A system for data processing in haematology (1974) (3)
Oxygen for ST-Segment-Elevation Myocardial Infarction: Still Up in the Air. (2015) (3)
Incorporation of radioactive folic acid into liver folate. (1972) (3)
A simple method for measuring iron absorption using a scintiscanner for whole-body counting. (1967) (3)
Iron deficiency and the oral mucous membrane. (1969) (3)
Catheter-based revascularization strategies for acute coronary syndromes in women. (2001) (3)
COMPARISON OF RATES OF BLEEDING AND VASCULAR COMPLICATIONS BEFORE, DURING, AND AFTER TRIAL ENROLLMENT IN THE SAFE-PCI TRIAL FOR WOMEN (2018) (3)
The use of a whole body counter for measuring bone marrow erythroid activity by profile scanning. (1974) (3)
Sequential blood counts and their variation in normal subjects. (1981) (3)
Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women. (2019) (3)
Enrichment of progenitor cells from human marrow. (1987) (3)
CRT-200.92 Gender Disparities in ST-Elevation Myocardial Infarction Care and Outcomes in Emerging Countries: A Global Lumen Organization for Women (GLOW) Initiative and Call to Action (2016) (3)
Abstract 2449: Clinical Outcomes in Women with Stable Coronary Artery Disease Randomized to Optimal Medical Therapy With or Without PCI: Pre-Specified Subset Analysis of the COURAGE Trial (2007) (2)
Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs (2020) (2)
Ferritin estimation by a radioimmunoassay technique: serum levels in normal subjects and patients with blood disorders. (1972) (2)
Revascularization for Stable Ischemic Heart Disease: The Courage to Use What We Have Learned. (2018) (2)
Gastric secretion and iron absorption. (1968) (2)
Abstract 4499: Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals With and Without Cardiac Surgery On-Site (2009) (2)
Proceedings: The recovery of haemopoietic progenitor cells in the mouse following cytotoxic agents. (1974) (2)
Coronary Angioplasty in Women: Is There an Increased Risk? (1994) (2)
2009 Focused Updates: STEMI and PCI Guidelines (2009) (2)
ACCF/AHA/SCAI CLINICAL COMPETENCE STATEMENT (2007) (2)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure [2] (multiple letters) (2005) (2)
Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding. (2005) (2)
Changing direction in ST-segment elevation myocardial infarction care: where do we go from here? (2010) (2)
The ISCHEMIA Trial: Was it Worth the Wait? (2020) (2)
Availability and absorption of dietary iron. (1970) (2)
Patients With ST-Elevation Myocardial Infarction : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of (2012) (2)
Proceedings: Rat liver tryptophan pyrrolase activity in iron deficiency anaemia. (1975) (2)
LACK OF SEX-BASED DIFFERENCES IN OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CORONARY ARTERY DISEASE TREATED WITH CONTEMPORARY MEDICAL THERAPY WITH OR WITHOUT PROMPT REVASCULARIZATION: A REPORT FROM BARI 2D (2010) (2)
Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021. (2022) (2)
TECHNOLOGY AND PRACTICE EXECUTIVE COMMITTEE (1998) (2)
Serum ferritin as a measure of body iron in primary idiopathic haemochromatosis. (1973) (2)
Priority test request form. (1979) (2)
RAS mutations in preleukaemias. (1989) (2)
Iron absorption from 'Feospan' capsules and ferrous sulphate tablets B.P. (1984) (2)
Report of the international working group on coronary sinus interventions (1986) (2)
Positron Emission Tomography-based Imaging of Transgene Expression Mediated by Replication-conditional , Oncolytic Herpes Simplex Virus Type 1 Mutant Vectors in Vivo 1 (2001) (2)
Regional systems of care for ST-elevation myocardial infarction: do they save lives? (2013) (2)
Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease (2021) (2)
GASTRIC IRON BINDING (1967) (2)
Challenges for the Basis of Practice The Role of Digoxin in the Treatment of Heart Failure (2008) (2)
Synchronized retroperfusion combined with coronary sinus occlusion: experimental measurements compared with simulation results and model predictions (1990) (2)
Letter: Increased serum iron in acute leukaemia. (1975) (2)
Vascular disease independently predicts worse outcome after percutaneous coronary intervention: Results from the NHLBI dynamic registry (2003) (1)
ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Perc (2016) (1)
Coronary sinus interventions: clinical application (1986) (1)
A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. (2003) (1)
Immunological abnormalities in iron deficiency anaemia. (1973) (1)
Economic consequences of restenosis: A model to compare relative costs of revascularization strategies (1990) (1)
The Challenge to Implement Systems of Care for ST-Segment–Elevation Myocardial Infarction (2016) (1)
Investigation of the stereochemistry of the tri- and tetra-ketide hydroxyacyl intermediates in the biosynthesis of the polyketide aspyrone in Aspergillus malleus using deuterium labelling and deuterium NMR spectroscopy (1995) (1)
PCI at hospitals with or without on-site cardiac surgery. (2013) (1)
Discrete bands in ferritin electrofocusing patterns. (1978) (1)
Guidelines Cardiology Foundation/American Heart Association Task Force on Practice of Asymptomatic Adults: Executive Summary: A Report of the American College 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in (2011) (1)
Gender differences in coronary revascularization: does age make a difference? (2004) (1)
Letter: Serum ferritin, alpha2 H globulin and malignant disease. (1975) (1)
Ferritin expression in transformed human haemopoietic cell lines. (1986) (1)
The benefit of prevention: engaging the public through strategic collaborations. (2004) (1)
Assessing Hospital Performance for Acute Myocardial Infarction: How Should Emergency Department Transfers Be Attributed (2015) (1)
Periprocedure myocardial infarction rates in the bypass angioplasty revascularization investigation (BARI) (1996) (1)
Mitotic index and migration inhibition factor: effect of two different culture media. (1973) (1)
738–1 Five Year Trends in the Treatment of Angiographically Documented Coronary Artery Disease: Experience of a Tertiary Care Center (1995) (1)
Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery (2019) (1)
Determinants of mortality when primary LV failure complicates acute myocardial infarction (2005) (1)
Reduced in vitro erythroid progenitor cell growth in bronchial cancer. (1987) (1)
preleukemia, leukemia, and lymphoid malignancies Increased circulating colony-stimulating factor-1 in patients with (2011) (1)
COMPARATIVE EFFECTIVENESS OF RADIAL AND FEMORAL APPROACHES TO PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A REPORT FROM THE NHLBI DYNAMIC REGISTRY (2010) (1)
Sideroblastic colonies in erythroid cultures grown from normal human marrow. (1985) (1)
Angioplasty for acute myocardial infarction in community hospital without surgical back-up: response to Wharton and Angelini publications "should guidelines be changed?: not whether but when". (2000) (1)
Randomized phase II study LD-ARAC plus rhGM-CSF in advanced myelodysplasia (1993) (1)
Fibrillation : ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial (2012) (1)
Safety and utility of early exercise testing after PTCA: Results of a randomized trial (1991) (1)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. (2005) (1)
Postgastrectomy anaemia and the Paterson-Kelly syndrome. (1969) (1)
Prehospital delay in patients with ST-segment elevation myocardial infarction: time for change. (2018) (1)
Outcomes in diabetic patients undergoing percutaneous coronary intervention: a report from the NHLBI dynamic registry (2002) (1)
Intervention for Multivessel Coronary Artery Disease A Decade of Improvement in the Clinical Outcomes of Percutaneous Coronary (2003) (1)
MORTALITY DIFFERENCES AMONG PATIENTS WITH IN-HOSPITAL ST-ELEVATION MYOCARDIAL INFARCTION (2019) (1)
Genetic abnormalities in myelodysplastic syndrome. (1991) (1)
Treatment for the myelodysplastic syndromes. (1987) (1)
Iron transport in the small intestinal cells. (1971) (1)
Myoglobin Depletion in Childhood Iron Deficiency (1981) (0)
Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women: Results of the SAFE-PCI for Women Quality-of-Life Substudy Short title: Hess et al.: QOL in SAFE-PCI for Women (2015) (0)
Interventions Catheterization: Endorsed by the Society for Cardiovascular Angiography and Task Force 3: Training in Diagnostic and Interventional Cardiac (2011) (0)
The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE study. (2022) (0)
THE EFFECT OF PRE-DISCHARGE EXERCISE TESTING ON ACTIVITY RECOMMENDATIONS AND PATIENT CONFIDENCE FOLLOWING PTCA (1990) (0)
Clinical and Procedural Predictors of Recurrent Restenosis after Coronary Balloon Angioplasty (1989) (0)
1080-45 Temporal trends in the treatment of total coronary occlusions (2004) (0)
The smoker's paradox in patients undergoing percutaneous coronary intervention: A report from the dynamic registry (2003) (0)
Abstract 2814: Temporal Changes in the Outcomes of Patients with Diabetes Mellitus Undergoing PCI in the NHLBI Dynamic Registry (2006) (0)
Abstract 18115: Are State Policies to Permit Pre-hospital Bypass Associated With Better Treatment Patterns Among Patients With ST-Elevation Myocardial Infarction? A Report From AHA's Mission: Lifeline Program (2015) (0)
Reassessing Patients Over Time : How To Follow Patients on Treatment (2009) (0)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. Authors' reply (2005) (0)
Emergency Interhospital Transfer of Patients With ST‐Segment–Elevation Myocardial Infarction: Call 9‐1‐1—The American Heart Association Mission: Lifeline Program (2022) (0)
Trends in door to balloon times among high-risk patients undergoing primary angioplasty (2003) (0)
Abstract 17725: Growth in Non-Emergency PCI at Hospitals Without Surgery-On-Site Since the Completion of the MASS COMM Trial - A Comparison of the MASS COMM RCT and Cohort Study (2013) (0)
Abstract 15215: Decreased Rates of Revascularization and Increased In-Hospital Mortality in Patients With Substance Use Disorders Admitted for Acute Coronary Syndromes (2018) (0)
1138-64 Major reduction in adverse outcomes of patients with congestive heart failure undergoing percutaneous coronary intervention: A comparison of the National Heart, Lung, and Blood Institute 1985–1986 percutaneous transluminal coronary angioplasty registry and the current dynamic registry (2004) (0)
Studies on progression and regression of coronary atherosclerosis: treatment with PTCA and antiplatelet agents (1990) (0)
Abstract 12612: Characteristics of Best Practice Primary PCI Timing for STEMI Transfer Patients: Findings From the AHA Mission: Lifeline Program® (2014) (0)
Do coronary risk factors influence lesion morphology? A report from the 1985–1986 NHLBI PTCA registry (1991) (0)
Report of the ACCF/AHA Consensus Conference on Professionalism and Ethics Ethics and Professionalism: Can There Be Consensus? : An Editorial Comment on the (2012) (0)
Abstract 14877: A Never Ending Tale of Pericarditis (2020) (0)
In-Hospital STEMI: An Inside Out Approach (2014) (0)
bypass grafting Effect of gender on postoperative outcomes and hospital stays after coronary artery (2013) (0)
Sex Differences in Presentation and Outcome Among Patients with Type 2 Diabetes and Coronary Artery Disease Treated With Contemporary Medical Therapy With or Without Prompt Revascularization: A Report From BARI 2D. (2013) (0)
The influence of coronary collaterals on the long term outcome of patients after unsucessful PICA a report from the 1985–1986, NHLBI PTCA registry (1991) (0)
41 Renal insufficiency, bleeding and prescription of discharge medication in patients undergoing percutaneous coronary intervention in the national heart, lung, and blood institute (NHLBI) dynamic registry (2016) (0)
Abstract 187: Sex-related Differences in Discharge Disposition for STEMI Care (2017) (0)
Address American Heart Association Scientific Sessions 2004 Rebuilding an Enduring Trust in Medicine: A Global Mandate: Presidential (2010) (0)
Does prior restenosis identify patients with a higher restenosis rate when undergoing subsequent PTCA of a new lesion (1990) (0)
Unstable versus stable angina in the current era: Comparison of percutaneous coronary intervention outcomes in the NHLBI dynamic registry (2003) (0)
Getting in and out: the RACE to primary percutaneous coronary intervention. (2011) (0)
Relation of Operator Volume and Access Site to Short-Term Mortality in Radial Versus Femoral Access for Primary Percutaneous Coronary Intervention. (2022) (0)
Faculty Opinions recommendation of Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot tr (2010) (0)
Reperfusion and Time to Presentation in Women: Too Little Too Late (2019) (0)
Synchronized Coronary Venous Retroperfusion During Coronary Angioplasty (1991) (0)
Patients: Executive Summary Development of Systems of Care for ST-Elevation Myocardial Infarction (2008) (0)
Women and Acute Coronary Syndromes (2003) (0)
Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women : Results of the SAFE-PCI for Women Quality-of-Life Substudy (2015) (0)
DIAGNOSIS OF DISTANT VESSEL CORONARY ARTERY DISEASE IN EARLY POST MYOCARDIAL INFARCTION STRESS TESTING (1984) (0)
Inter-observer Agreement about Out-of-hospital Notification of Acute ST Segment Elevation Myocardial Infarction (2007) (0)
Percutaneous Coronary Intervention Without Onsite Cardiac Surgery: Ready for Take-Off? (2015) (0)
Mortality differences among patients with in‐hospital ST‐elevation myocardial infarction (2020) (0)
Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York. (2023) (0)
Improving the quality of care in cardiac surgery — the role of the 'mortality' meeting (2011) (0)
Cardiogenic shock complicating myocardial infarction without ST segment elevation: Final report from the SHOCK registry (1999) (0)
Abstract 4297: The Impact of Vascular Complications and Advanced Age on Outcomes Following Percutaneous Coronary Intervention (2009) (0)
Response to letters regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease". (2014) (0)
The effect of cytosine arabinoside on CFU-GM from patients with myelodysplastic syndrome. (1987) (0)
Irish cardiac society (1990) (0)
Abstract 18556: Trends in Door-to-Balloon Time and Mortality in STEMI Patients Undergoing Primary PCI in Massachusetts (2012) (0)
Proceedings: The effect of iron deficiency on tissues. (1974) (0)
12 Occupational and environmental exposures and the myelodysplastic syndromes: A case-control study (1997) (0)
Preleukaemia and myelodysplastic syndromes today. (1989) (0)
1062-47 Marked improvements in in-hospital outcomes following contemporary percutaneous coronary intervention in patients with diabetes (2004) (0)
The Emperor's New Clothes Are Loose: Lower Body Mass Index, Not Calorie Restriction, Accounts for Improved Diastolic Function (2006) (0)
The effect of microcytosis on red cell constituents (1967) (0)
PREVALENCE OF PARIETAL-CELL ANTIBODIES (1964) (0)
Haemopoietic factors Iron absorption (2005) (0)
Discussion of Poster Session II (1992) (0)
Sideroblastic erythropoeisis in subjects with minimal or no anaemia Table Haematological datafrom six patients with sideroplastic erythropoiesis Case I Case 2 Case 3 Case 4 CaseS Case (2005) (0)
TCT-336 Higher Rates of Repeat Coronary Revascularizations in Young Women (2013) (0)
Estrogen replacement therapy. (2000) (0)
Abstract 13504: Mortality in STEMI Patients Undergoing Inter-Hospital Transfer for Primary PCI in Massachusetts (2010) (0)
Abstract 2868: Sex, Clinical Symptoms and Angiographic Findings at Baseline in BARI 2D (2007) (0)
Laboratory techniques Assessment of DNA content and cell cycle distribution of erythroid and myeloid cells from bone marrow (2005) (0)
PRESCRIBING IRON TO COMBAT DEPRIVATION (1987) (0)
Cyclic haemopoiesis in association with familial refractory anaemia (1991) (0)
SUMMARY Thealkaline phosphatase-antialkaline phosphatase (APAAP)immunocytochemical staining technique was usedtolookforcirculating cells ofmegakaryocyte lineage inperipheral blood smearsfrom67casesofmyelodysplasia. Small numbers ofmicromegakaryocytes (2017) (0)
FURTHER INQUIRY INTO NHS EFFICIENCY (1983) (0)
Carbohydrates andsulphur-containi ng compounds intheanaemic buccal epithelium (1961) (0)
Cardiogenic shock without ST segment elevation myocardial infarction: Observations and implications (1997) (0)
Letter: Iron stores and iron absorption. (1973) (0)
Women Versus Men Regarding Outcome of CABG or PTCA Response (1999) (0)
MASS COM Trial: Nonemergency PCI Safe without on-Site Surgery Capability (2013) (0)
Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality (2023) (0)
Outcome after a Third Coronary Angioplasty for Recurrent Native Coronary Artery Restenosis (1990) (0)
blood and bone marrow in polycythaemia . Erythroid colony growth from peripheral (0)
Abstract 15501: Successes and Ongoing Opportunities in National Efforts to Improve STEMI Care: Mission: Lifeline Update 2010-2018 (2019) (0)
DISCRETE BANDS IN FERRITIN ELECTROFOCUSING PATTERNS (1978) (0)
Coronary Angioplasty (2005) (0)
Does low dose intracororary rt-PA lyse chronic thrombotic occlusions prior to PTCA? (1990) (0)
Review article Myelodysplastic syndromes: pathogenesis, functional abnormalities, andclinical implications (1985) (0)
Great Britain Properties of Human Tissue Isoferritins (2005) (0)
A statistical model to predict risk for hemodynamic compromise during coronary angioplasty (1991) (0)
Iron absorption (1971) (0)
Acute coronary syndrome in a young woman. (2001) (0)
FERRITINAEMIAINLEUKAEMIA AND HODGKIN'S DISEASE (1973) (0)
Theeffect ofiron stores oniron absorption inthe rat:Thepossible role ofcirculating ferritin (1975) (0)
Microfilariae of Brugia pahangi in the Blood of Cats Have Variable Levels of Feline IgG on Their Sheaths (1989) (0)
Cooley's Anæmia (1948) (0)
Iron losses and iron requirements. (1971) (0)
Extra Corporeal Membrane Oxygenation and Long Term Neurological Function Among COVID-19 Patients (2021) (0)
Chairman's Closing Comments (2008) (0)
Asissment of intracoronary fibrin metabolism after coronary angioplasty in man (1990) (0)
Phagocytosis innormal andanaemic blood (1964) (0)
Roleofgastric secretion inironabsorption (1969) (0)
Reply: Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease? (2015) (0)
Proceedings: Observations on chelatable iron and ferritin in haemochromatosis. (1974) (0)
Running title: Nedeljkovic et al.; Oxygen for STEMI (2015) (0)
Protecting schools from pesticides. (1999) (0)
Abstract 17065: Final Results of the AHA Guideline Transformation Optimization Initiative (2018) (0)
Abstract 913: Persistent High Risk of Death and Myocardial Infarction in Patients with Peripheral Arterial Disease Undergoing PCI: Results from the NHLBI Dynamic Registry (2008) (0)
THE UTILITY OF POSITRON EMISSION TOMOGRAPHY (PET) MYOCARDIAL PERFUSION IMAGING (MPI) IN THE ASSESSMENT OF CORONARY ARTERY DISEASE IN PATIENTS WITH APICAL HYPERTROPHIC CARDIOMYOPATHY: FRIEND OR FOE? (2020) (0)
Retinoic Acid Therapy in the Myelodysplastic Syndrome (1992) (0)
Abstract 12192: Improving Care of ST Segment Elevation Myocardial Infarction in the United States 2008 to 2012: A Report From Mission: Lifeline (2013) (0)
[Remission of incomplete paraplegia after thoracic stent graft implantation. Case report and review of the literature]. (2012) (0)
Acute Ischemic Syndromes (2004) (0)
DNA index andkaryotype analysis inmyelodysplasia (1989) (0)
Acute Myocardial Infarction ( AMI ) Advisory Primary Percutaneous Coronary Intervention ST-Segment – Elevation Myocardial Infarction Patients With Timely (2006) (0)
Abstract 19058: STEMI Patients Presenting to Non PCI Capable Hospitals in New York State: Treatment Strategies and 30-Day Mortality (2016) (0)
Cyclical haemopoiesis in association with familial refractory anaemia: cycling of progenitors and serum growth factor concentrations (1992) (0)
In-vitro response of myeloid progenitors to phytohaemagglutin and interleukin-2 is related to survival of some myelodysplastic patients [Abstract] (1993) (0)
A BCNU-containing Regimen, Mini-BEAM, with GM-CSF is a Safe and Effective Mobilizing Regimen Pre-stem Cell Transplantation in Lymphoma Patients. (1997) (0)
The accumulation of storage iron in patients treated for iron deficiency anaemia [proceedings]. (1975) (0)
Iron Balance and its Disorders (1970) (0)
with serum ferritin concentration . haemochromatosis : relationship and patients with idiopathic Iron absorption in normal subjects (0)
Iron binding proteins (1979) (0)
Herpes Simplex Virus Type 1 Mutant Vectors in Vivo Expression Mediated by Replication-conditional, Oncolytic Positron Emission Tomography-based Imaging of Transgene (2013) (0)
Proceedings: Ferritin in normal and leukaemic white blood cells. (1974) (0)
ras Mutations in Preleukaemia, in Patients Following Cytotoxic Therapy and in Normal Subjects (1991) (0)
Subcellular changes in 59Fe distribution during iron absorption in the rat. (1971) (0)
124I]FIAU in Cat and Man (2001) (0)
Effect ofgastric juice oniron absorption in patients withgastric atrophy (1969) (0)
Letter: Correlation between iron content of epithelial cells and iron absorption. (1974) (0)
GASTRIC ACID IN IRON-DEFICIENCY ANÆMIA (1966) (0)
Pathogenesis of Anaemia in the Myelodysplastic Syndrome (1992) (0)
Myelodysplasia: pathogenesis and functional aspects. (1989) (0)
Aminoacylation-independent and cell-autonomous neuronal dysfunction (2009) (0)
c-myc and c-myb oncoproteins during induced maturation of human myeloid and erythroid leukaemic lines. (1989) (0)
Drosophila as a platform to predict the pathogenicity of novel aminoacyl-tRNA synthetase mutations in CMT (2011) (0)
O17.6 Incidence and prognosis of intra-abdominal hypertension and abdominal compartment syndrome in severely burned patients (2011) (0)
Benzene Haematotoxicity and Leukaemia (1989) (0)
Corrigendum to “Synaptopodin and 4 novel genes identified in primary sensory neurons” [Mol. Cell. Neurosci. 30 (2005) 316–325] (2006) (0)
SYNTHESIS AND ANALGESIC-ANTIINFLAMMATORY ACTIVITY OF SOME 4- AND 5-SUBSTITUTED HETEROARYLSALICYLIC ACIDS (1979) (0)
1424. Central Nervous System Tuberculosis in a Large Healthcare System (2022) (0)
Electrophilic Sulfenylation in a Stereocontrolled Synthesis of Protected (2R,3R)‐3‐Mercaptoaspartic Acid from L‐Aspartic Acid. (1997) (0)
Refractory anaemia in the glucagonoma syndrome. (1981) (0)
1,3‐Halogen shift of 2‐halogeno‐4,5‐dimethylphenols following oxidation with Fremy's salt (1986) (0)
A Stereocontrolled Synthesis of Protected (2R,3R)-3-Mercaptoaspartic Acid via a β-Aspartyl Enolate Sulfenylation. (1996) (0)
1,3‐Halogen Shift of 2‐Halogeno‐4,5‐dimethylphenols Following Oxidation with Fremy′s Salt. (1986) (0)
Has Prasugrel Been Compared Correctly With Clopidogrel in Non–ST-Segment Elevation Acute Coronary Syndrome? (0)

This paper list is powered by the following services:

Other Resources About Alice K. Jacobs

en.wikipedia.org

What Schools Are Affiliated With Alice K. Jacobs?

Alice K. Jacobs is affiliated with the following schools: